publication venue for
- Lipids, safety parameters, and drug concentrations after an additional 2 years of treatment with anacetrapib in the DEFINE study.. 19. 2014
- The cyclic GMP modulators YC-1 and zaprinast reduce vessel remodeling through antiproliferative and proapoptotic effects.. 14. 2009
- Electrophysiologic effects of a novel selective adenosine A1 agonist (CVT-510) on atrioventricular nodal conduction in humans.. 6. 2001
- Exercise tolerance and quality of life in elderly patients with chronic atrial fibrillation.. 6. 2001
- Electrophysiologic and Antiarrhythmic Effects of Propafenone: Focus on Atrial Fibrillation.. 4. 1999
- Recurrent Torsades de Pointes After Sotalol Therapy for Symptomatic Paroxysmal Atrial Fibrillation in a Patient with End-Stage Renal Disease.. 4. 1999
- Efficacy of Nicardipine for Long-Term Therapy of Chronic Stable Angina.. 3. 1998
- Local Delivery of an Ultra-short-acting Nitric Oxide-releasing Compound, DMHD/NO, Is Highly Effective in Inhibiting Acute Platelet-Thrombus Formation on Injured Arterial Strips.. 2. 1997
- Pharmacologic therapy for reducing myocardial infarct size in clinical trials: failed and promising approaches. 2014
- Dabigatran: comparison to warfarin, pathway to approval, and practical guidelines for use. 2012
- Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents. 2005
- Extended-Duration Thromboprophylaxis Among Acute Medically Ill Patients: An Unmet Need. 2015